Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
38 results about "Senile deafness" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Senile. pertaining to old age; manifesting senility. senile deafness. due probably to degeneration of the hair cells in the organ of Corti, and to loss of neurons in the spinal ganglion; called also presbycusis. senile osteoporosis. reduced mineralization of bone due to advanced age. senile retinopathy. see senile retinopathy.
Compositions and methods for treatment of ear disorders
ActiveUS20110142917A1Reduces and inhibits expression of geneReduce expressionHeavy metal active ingredientsOrganic active ingredientsDiseasePresbycusis
The present invention relates to pharmaceutical compositions useful for topical, non-invasive delivery of an oligonucleotide to the ear and to methods for the treatment of an ear disorder, including hearing loss arising from chemical-induced ototoxicity, acoustic trauma and presbycusis; and microbial infections. The method comprises topically administering to the ear of a subject in need thereof a pharmaceutical composition comprising an inhibitory oligonucleotide, a permeability enhancer and a pharmaceutically acceptable carrier, wherein the oligonucleotide reduces or inhibits expression of a gene associated with the ear disorder in the subject.
Owner:QUARK FARMACUITIKALS INC
Treatment and/or Prevention of Presbycusis by Modulation of Metabotropic Glutamate Receptor 7
The invention relates to the treatment and / or prevention of age-related hearing loss (presbycusis) with a modulator of a metabotropic glutamate receptor 7 (mGluR7).
Owner:UNIVERSITY OF ANTWERP +2
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
ActiveUS8268866B2Suppress and reduce NMDA receptor mediated aberrant activityPreventing and treating tinnitusHalogenated hydrocarbon active ingredientsBiocideNR1 NMDA receptorPresbycusis
The invention relates to methods for the prevention and / or treatment of tinnitus induced by cochlear excitotoxicity. In these methods, a pharmaceutical composition comprising an NMDA receptor antagonist is administered to an individual in need of such treatment by appropriate devices and / or formulations for local administration to the inner ear. The tinnitus to be prevented and / or treated may be provoked by acoustic trauma, presbycusis, ischemia, anoxia, sudden deafness, or other cochlear excitotoxic-inducing occurrence.
Owner:AURIS MEDICAL AG
Health-care wine
InactiveCN101125169AImprove memory lossSignificant ability to repair and regenerateDigestive systemAlcoholic beverage preparationForest yamWolfiporia extensa
The present invention relates to a health care wine, in particular to a health care wire which contains the traditional Chinese medicine for nourishing yin, the existing health care wines are mostly the wines for strengthening yang, which can cause the imbalance between yin and yang by excessive drinking; China has a word that yang mainly controls the organs and yin mainly controls body fluids, the excess of yang often causes qi stagnation and blood stasis, so as to cause cardiovascular diseases, hearing loss, memory impairment and alopecia. The components of the present invention include: beverage wine, each 1000 parts by weight of the beverage wine is added with 30 parts of radix rehmanniae glutinosae, 30 parts of radix rehmanniae preparata, 20 parts of common yam rhizome, 20 parts of common macrocarpium fruit, 20 parts of barbary wolfberry fruit, 15 parts of glossy privet fruit, 15 parts of tree peony bark, 20 parts of hawthorn fruit, 30 parts of tuber fleeceflower root, 30 parts of salvia, 30 parts of membranous milkvetch root, 20 parts of Chinese magnoliavine fruit, 15 parts of oriental waterplantain rhizome, 15 parts of Indian buead and 15 parts of kudzuvine root, and all the components are soaked for 25 to 40 days and then the wastes are removed. The product can be used as the health care wine for the treatment of age related hearing loss, alopecia, bad memory and the improvement of the cardiovascular adverse states.
Owner:孙景荣
Electronically compensated micro-speakers
InactiveUS20120275622A1Correct such hearing deficienciesFrequency response correctionTransmission noise suppressionOctavePeak value
Electronics for altering the audio frequency response of a micro-speaker without modifying the micro-speaker itself are used to provide a selected frequency response of the micro-speaker. The micro-speaker has a resonant peak region, from which the response declines for both higher and lower frequencies. In one embodiment the electronics includes a first circuit for modifying the frequency response curve up to the resonant peak region, and a second circuit for modifying the frequency response curve for audio frequencies higher than this region. Each filter yields an integer multiple of 6 dB per octave slope. In the described embodiment, for approximately correcting presbyacusis (age related hearing loss), a set of high pass filters, low pass filters, and / or high order filters are connected to the micro-speaker to progressively attenuate the frequency response curve as the frequency decreases from 10000 Hz to 100 Hz.
Owner:GOBELI GARTH WILLIAM +1
Compositions and methods for treatment of ear disorders
ActiveUS8431692B2Reduce expressionImprove stabilityHeavy metal active ingredientsOrganic active ingredientsOtotoxicityNon invasive
The present invention relates to pharmaceutical compositions useful for topical, non-invasive delivery of an oligonucleotide to the ear and to methods for the treatment of an ear disorder, including hearing loss arising from chemical-induced ototoxicity, acoustic trauma and presbycusis; and microbial infections. The method comprises topically administering to the ear of a subject in need thereof a pharmaceutical composition comprising an inhibitory oligonucleotide, a permeability enhancer and a pharmaceutically acceptable carrier, wherein the oligonucleotide reduces or inhibits expression of a gene associated with the ear disorder in the subject.
Owner:QUARK FARMACUITIKALS INC
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
ActiveUS8507525B2Suppress and reduce NMDA receptor mediated aberrant activityPreventing and treating tinnitusCompounds screening/testingBiocideNR1 NMDA receptorPresbycusis
The invention relates to methods for the prevention and / or treatment of tinnitus induced by cochlear excitotoxicity. In these methods, a pharmaceutical composition comprising an NMDA receptor antagonist is administered to an individual in need of such treatment by appropriate devices and / or formulations for local administration to the inner ear. The tinnitus to be prevented and / or treated may be provoked by acoustic trauma, presbycusis, ischemia, anoxia, treatment with one or more ototoxic medications, sudden deafness, or other cochlear excitotoxic-inducing occurrence. The invention also relates to method for the identification of compounds effective in the treatment and prevention of tinnitus by a novel screening method incorporating an electrophysiological test method.
Owner:AURIS MEDICAL AG
Traditional Chinese medicine for treating deaf
InactiveCN101125165AReduce peripheral resistanceEnhance the effect of qi and blood circulationHeavy metal active ingredientsSenses disorderMonkshoodsChinese traditional
The present invention relates to a traditional Chinese medicine for treating deafness, in particular to a Chinese traditional patent medicine which is prepared by taking the Chinese herbal medicines as the pharmaceutical raw materials and is suitable for both internal application and external application. The present invention includes the pharmaceutical raw materials with the following parts by weight: 3 to 7 parts of Szechuan lovage rhizome, 3 to 7 parts of earthworm and 2 to 7 parts of grassleaf sweelflag rhizome. The pharmaceutical raw materials can be added with 0.05 to 0.5 part of musk, 0.05 to 0.5 part of borneol, the externally applied medicine can also be added with 2 to 7 parts of common monkshood mother root and 0.5 to 1.5 parts of magnetite. Ointment prepared by using the scallion juice is the best form for external administration. The traditional Chinese medicine of the present invention has the effects of activating qi, activating blood circulation and dredging channel blockage, and the total effective rate for the chronic deafness, sudden deafness, traumatic deafness, explosive deafness and age related hearing loss is more than 93 percent.
Owner:李启迎
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
ActiveUS20100254907A1Suppress and reduce NMDA receptor mediated aberrant activityPreventing and treating tinnitusCompounds screening/testingBiocideNR1 NMDA receptorPresbycusis
Owner:AURIS MEDICAL AG
Erlong Fucong Pill for curing deafness
The present invention relates to a Chinese medicine preparation with the functions of promoting blood circulation, removing stasis, supplementing blood, nourishing blood, clearing away heat and removing toxic material, etc. for curing deefness, including senile deafness, nerve deafness, ischemic deafness, deafness due to drug intoxication, sudden deafness and other deafness due to various diseases. The Chinese medicine preparation is made up by using 24 Chinese medicinal materials of saffron, red peony root, peach kernel, Chinese angelica root, ligusticum root and others.
Owner:张学政
Traditional Chinese medicine for treating presbycusis and preparation method of traditional Chinese medicine
InactiveCN103816344ASymptoms disappearRelieve symptomsHeavy metal active ingredientsSenses disorderSide effectChinese knotweed
The invention discloses a traditional Chinese medicine for treating presbycusis, which is characterized by comprising the following medicinal materials by weight: 12-15 parts of radix rehmanniae praeparata, 12-15 parts of Chinese yam rhizome, 8-10 parts of fructus corni, 8-10 parts of the root bark of the peony tree, 8-10 parts of poria cocos, 8-10 parts of rhizoma alismatis, 8-10 parts of the fruit of Chinese magnoliavine, 12-15 parts of magnetite, 8-10 parts of rhizoma acori graminei, 12-15 parts of abutilon indicum, 8-10 parts of fructus psoraleae, 0-6 parts of Chinese knotweed root and 0-8 parts of glabrous gardneria stem. The preparation method comprises the following steps: weighing the medicinal materials, putting the medicinal materials in the container, adding 8 times amount of water, decocting for 1.5 h, and filtering; adding 6 times amount of water in the filter residue, decocting for 1 h, and filtering; mixing the filtrates, concentrating, drying, and arranging in capsule shells. Clinical experiments prove that the remarkable effect of treating the presbycusis is achieved through selecting appropriate medicinal materials and the ratio thereof, and the traditional Chinese medicine is safe, and has no toxic or side effects.
Owner:郑鑫
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
InactiveUS9072662B2Suppress and reduce NMDA receptor mediated aberrant activityPreventing and treating tinnitusOrganic active ingredientsAerosol deliveryPresbycusisScreening method
Owner:AURIS MEDICAL AG +1
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
InactiveUS20150057360A1Suppress and reduce NMDA receptor mediated aberrant activityPreventing and treating tinnitusOrganic active ingredientsBiocideNR1 NMDA receptorPresbycusis
The invention relates to methods for the prevention and / or treatment of tinnitus induced by cochlear excitotoxicity. In these methods, a pharmaceutical composition comprising an NMDA receptor antagonist is administered to an individual in need of such treatment by appropriate devices and / or formulations for local administration to the inner ear. The tinnitus to be prevented and / or treated may be provoked by acoustic trauma, presbycusis, ischemia, anoxia, treatment with one or more ototoxic medications, sudden deafness, or other cochlear excitotoxic-inducing occurrence. The invention also relates to method for the identification of compounds effective in the treatment and prevention of tinnitus by a novel screening method incorporating an electrophysiological test method.
Owner:AURIS MEDICAL AG +1
Health-care wine
InactiveCN101125169BImprove memory lossSignificant ability to repair and regenerateDigestive systemAlcoholic beverage preparationWolfiporia extensaRhizome
The present invention relates to a health care wine, in particular to a health care wire which contains the traditional Chinese medicine for nourishing yin, the existing health care wines are mostly the wines for strengthening yang, which can cause the imbalance between yin and yang by excessive drinking; China has a word that yang mainly controls the organs and yin mainly controls body fluids, the excess of yang often causes qi stagnation and blood stasis, so as to cause cardiovascular diseases, hearing loss, memory impairment and alopecia. The components of the present invention include: beverage wine, each 1000 parts by weight of the beverage wine is added with 30 parts of radix rehmanniae glutinosae, 30 parts of radix rehmanniae preparata, 20 parts of common yam rhizome, 20 parts of common macrocarpium fruit, 20 parts of barbary wolfberry fruit, 15 parts of glossy privet fruit, 15 parts of tree peony bark, 20 parts of hawthorn fruit, 30 parts of tuber fleeceflower root, 30 parts ofsalvia, 30 parts of membranous milkvetch root, 20 parts of Chinese magnoliavine fruit, 15 parts of oriental waterplantain rhizome, 15 parts of Indian buead and 15 parts of kudzuvine root, and all thecomponents are soaked for 25 to 40 days and then the wastes are removed. The product can be used as the health care wine for the treatment of age related hearing loss, alopecia, bad memory and the improvement of the cardiovascular adverse states.
Owner:孙景荣
Compositions and methods for treating neurodegenerative diseases
ActiveUS20090169533A1Prevents and reduces lossRelieve symptomsBiocideSenses disorderDiseaseSenile deafness
Owner:MARINE BIO
Chinese herbal preparation for presbycusis and preparation method of preparation
InactiveCN103349723AReduce pressure on blood vesselsPromote blood circulationSenses disorderAnthropod material medical ingredientsHerbal preparationsSide effect
The invention relates to a Chinese herbal preparation for presbycusis and a preparation method of the preparation. The Chinese herbal preparation comprises the following active ingredient materials: akebiaquinata, broadleaf holly leaf, sunflower disc, mahonia bealei carr, piemarker, chandali fruit, lytta caraganae, scarlet swertia herb, yichang meadow rue, rhizoma calami, honewort, duck fat, rosin, tricuspid cudrania bark, rhizoma arisaematis and bamboo leaf flavones. The Chinese herbal preparation disclosed by the invention has the effects of nourishing kidneys and protecting liver, nourishing heart and improving brain fitness, restoring menstrual flow for resuscitation, clearing away heat and toxic materials and the like, can be used for effectively relieving ear blood vessel pressure and promoting ear blood circulation, so that a special treatment effect is achieved for treating both symptoms and root causes of the presbycusis. The Chinese herbal preparation is used for treating presbycusis and conforms to the traditional Chinese medicine and modern pharmacological research theory. Besides, the Chinese herbal preparation is appropriate in selected material compatibility, remarkable in treatment effect, high in safety performance, free of side effect, low in price and worthy of wide popularization and application.
Owner:卢晓梅
Traditional Chinese Medicine for Sudden Deafness and Tinnitus
InactiveCN101810772BTo achieve the purpose of treating sudden deafnessHeavy metal active ingredientsSenses disorderSide effectMedicine
The invention relates to a Chinese medicament for curing sudden deafness and tinnitus, which adopts the following technical scheme that: the Chinese medicament is prepared from the following raw material medicaments in part by weight: 15 to 25 parts of rehmannia glutinosa, 10 to 20 parts of root of rehmannia, 5 to 15 parts of common yam rhizome, 5 to 15 parts of common macrocarpium fruit, 10 to 20 parts of siberian solomonseal rhizome, 10 to 20 parts of himalayan teasel root, 5 to 15 parts of cortex moutan, 5 to 15 parts of oriental waterplantain rhizome, 10 to 15 parts of Indian buead, 5 to 15 parts of golden thread, 15 to 25 parts of spiny jujube kernel, 15 to 25 parts of magnetite, 10 to 20 parts of dragon's bone, 10 to 20 parts of oyster, 5 to 15 parts of akebia stem and 5 to 15 parts of thinleaf milkwort root-bark. The Chinese medicament can relieve and eliminate the pain caused by the sudden deafness for patients and has good curative effect and no side effect.
Owner:李天夫
Traditional Chinese medicinal composition for treating presbycusis
InactiveCN103585480ALow cost of treatmentEffective treatmentSenses disorderInanimate material medical ingredientsSide effectOyster
The invention relates to a traditional Chinese medicinal composition for treating presbycusis. The traditional Chinese medicinal composition is composed of the following components: by weight, 20-30 parts of eucommia, 20-30 parts of teasel root, 20-30 parts of cibotium barometz, 10-20 parts of keel, 10-20 parts of oyster, 10-20 parts of abalone shell, 10-20 parts of rhizoma Gastrodiae, 5-10 parts of cynanchum paniculatum, 5-10 parts of mulberry leaf and 5-10 parts of Bungarus Parvus. The traditional Chinese medicinal composition has a reasonable pharmaceutical formulation, is safe, has no side effect, requires low treatment cost, has a function of simultaneously treating principal and subordinate symptoms, and can be used to effectively treat presbycusis of the deficiency type of liver-yin and kidney-yin.
Owner:金福娥
Electronically compensated micro-speakers
InactiveUS8787606B2Correct such hearing deficienciesFrequency response correctionTransmission noise suppressionOctavePeak value
Electronics for altering the audio frequency response of a micro-speaker without modifying the micro-speaker itself are used to provide a selected frequency response of the micro-speaker. The micro-speaker has a resonant peak region, from which the response declines for both higher and lower frequencies. In one embodiment the electronics includes a first circuit for modifying the frequency response curve up to the resonant peak region, and a second circuit for modifying the frequency response curve for audio frequencies higher than this region. Each filter yields an integer multiple of 6 dB per octave slope. In the described embodiment, for approximately correcting presbyacusis (age related hearing loss), a set of high pass filters, low pass filters, and / or high order filters are connected to the micro-speaker to progressively attenuate the frequency response curve as the frequency decreases from 10000 Hz to 100 Hz.
Owner:GOBELI GARTH WILLIAM +1
Healthcare wine for senile deafness
InactiveCN102965250AHas the effect of adjuvant therapyReasonable formulaSenses disorderAlcoholic beverage preparationWolfiporia extensaGLYCYRRHIZA EXTRACT
The invention discloses a healthcare wine for senile deafness. The healthcare wine comprises a potable spirit and is characterized in that 30 parts of prepared rehmannia root, 20 parts of hawthorn, 15 parts of the fruit of Chinese wolfberry, 30 parts of Chinese magnoliavine fruit, 20 parts of liquorice, 30 parts of polygonum multiflorum, 20 parts of dogwood, 15 parts of glossy privet fruit, 15 parts of rhizoma alismatis, 15 parts of tuckahoe, 20 parts of almond and 30 parts of walnut are added to every 1000 parts of portable spirit in parts by weight, the mixture is soaked for 30-40 days, dregs are removed from mixture, and a liquid supernatant is obtained. The healthcare wine for senile deafness is reasonable in formula and low in cost and has an adjuvant therapy effect on senile deafness and efficacies of tonifying kidney, protecting liver, nourishing heart and invigorating brain.
Owner:青岛本草生物科技有限公司
BK channel-modulating peptides and their use
The present invention concerns peptides and nucleic acids encoding the peptides, and their use for modulating large conductance Ca2+ activated K+ (BK) channel activity in cells; for treating conditions such as presbycusis (age-related hearing loss), audiogenic seizures, alcohol addiction, cancer, and neurodegenerative disease; and for delivering a cargo moiety to the brain of a subject through the blood-brain barrier.
Owner:UNIV OF SOUTH FLORIDA +1
Medicine for treating presbycusis and preparation method thereof
InactiveCN106074876ACompatibleIn line with traditional Chinese medicineSenses disorderPteridophyta/filicophyta medical ingredientsTreatment effectModern medicine
The invention discloses a medicine for treating presbycusis and a preparation method and belongs to the field of traditional Chinese medicines. The medicine is prepared from effective components including herb of Indian abutilon, all-grass of fourfinger rattanpalm, pink plumepoppy herb, flowers of cherokee rose, leaves of betel pepper, radix angelicae, roots of common bombax, herb of common corydalis, amur barberry roots, herba cistanches, herb of Indian kalimeris, leaves of broadleaf holly, lygodium microphyllum (Cav.) R.Br., semen sinapis, Indian stringbush roots and lucid ganoderma. The selected medicinal materials are compatible, and the medicine conforms to the traditional Chinese medicine and pharmacy and modern medicine and pharmacology theories, has effects of dispelling wind, clearing heat, tonifying qi, opening apertures, promoting the circulation of qi and reducing phlegm and has a unique curative effect of treating presbycusis; the treatment effect is remarkable, relapse does not occur after curing, the medicine is safe and has no toxic or side effect, the cost is low, a person can normally work and live in the medicine taking period, and the medicine is effective, practical and worth wide application and popularization clinically.
Owner:李益香
Traditional Chinese medicine composition for treating presbycusis
The invention discloses a traditional Chinese medicine composition for treating presbycusis, and belongs to the technical field of traditional Chinese medicines. Traditional Chinese medicines including roots of Schoepfia jasminodora Sieb,et Zucc., leaves, bark and roots of Viburnum odoratissimum Ker, Melochia corchorifolia L., Cardamine hirsuta L., all grass of Oxalis acetosella L., rhizome of Humata repens (L. f.) Diels, Themeda triandra Forsk. Var. Japonica (Willd. )Makino, all grass of Panzeria alashanica Kupr, Fructus Alpinae Oxyphyllae, roots of Aralia melanocarpa(Levl.)Lauener, all grass of Geum urbanum L. and raspberries which have the functions of tonifying kidneys, invigorating blood circulation, tonifying qi, replenishing essence, clearing heat and promoting diuresis are selected for pathogenesis of presbycusis according to the syndrome differentiation depending treatment theory and decocted with water into decoction, and it is proved through clinical tests that the total effective rate reaches 95.2%.
Owner:葛传芳
Traditional Chinese medicine for treating deaf
InactiveCN100531764CReduce peripheral resistanceEnhance the effect of qi and blood circulationHeavy metal active ingredientsSenses disorderChinese traditionalTraumatic deafness
Owner:李启迎
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
InactiveCN1972677AInhibit or reduce abnormal activityHalogenated hydrocarbon active ingredientsSenses disorderNR1 NMDA receptorPresbycusis
The invention relates to methods for the prevention and / or treatment of tinnitus induced by cochlear excitotoxicity. In these methods, a pharmaceutical composition comprising an NMDA receptor antagonist is administered to an individual in need of such treatment by appropriate devices and / or formulations for local administration to the inner ear. The tinnitus to be prevented and / or treated may be provoked by acoustic trauma, presbycusis, ischemia, anoxia, treatment with one or more ototoxic medications, sudden deafness, or other cochlear excitotoxic-inducing occurrence.
Owner:AURIS MEDICAL AG +1
Medicine composition for preventing and treating presbycusis
InactiveCN106540239APrevent the development of hyperresponsivenessElimination increaseSenses disorderPeptide/protein ingredientsSenile deafnessVeterinary medicine
The invention discloses a medicine composition for preventing and treating presbycusis. The effective components comprise Trefolane A and antide acetate. By weight, the ratio of the Trefolane A to the antide acetate is 1:1-20:1. The medicine composition for preventing and treating the presbycusis has a good effect on prevention and treatment of the presbycusis.
Owner:徐州诺克非医药科技有限公司
Compositions and methods for treating neurodegenerative diseases
Owner:MARINE BIO CO LTD
A traditional Chinese medicine preparation for presbycusis and its preparation method
InactiveCN103349723BReduce pressure on blood vesselsPromote circulationSenses disorderAnthropod material medical ingredientsHerbal preparationsSide effect
The invention relates to a traditional Chinese medicine preparation for presbycusis and a preparation method. The raw materials of the active ingredients of the traditional Chinese medicine preparation are composed of: Mutong, Kudingcha, sunflower receptacle, Gong Laozi, Abutilon, quinoa, Qingniangzi, mountain Piaoercao, rock broom, Baichang, Mopancao, wild goose fat, rosin, Zhemu white bark, Tian Nanxing and Bamboo leaf ginseng; the traditional Chinese medicine preparation of the present invention has the functions of invigorating the kidney, protecting the liver, nourishing the heart and strengthening the brain, clearing the meridians and opening the orifices, dispelling wind, clearing heat and detoxifying It can reduce the pressure of blood vessels in the ear and promote the blood circulation in the ear, so as to achieve a unique therapeutic effect, and achieve the purpose of treating both the symptoms and the root causes of deafness; the traditional Chinese medicine preparation of the present invention is used for the treatment of presbycusis, which conforms to the theory of traditional Chinese medicine and modern pharmacological research. The selected medicinal materials are suitable for compatibility, obvious curative effect, high safety performance, no side effects and low price, and are worthy of widespread application.
Owner:卢晓梅
Composition for relieving presbycusis and tinnitus and preparation method of composition
InactiveCN105596692AFormulation ScienceEasy to prepareSenses disorderPill deliveryPalpitationsPresbycusis
The invention discloses composition for relieving presbycusis and tinnitus and a preparation method of the composition. The composition is mainly prepared from raw materials in parts by weight as follows: 3-9 parts of Chinese angelica, 3-9 parts of yine abrus, 6-10 parts of honeysuckle, 2-8 parts of kudzuvine roots, 6-10 parts of benzoin, 3-6 parts of golden thread, 4-9 parts of common dysosmatis rhizomes and roots, 10-18 parts of glossy privet fruits, 3-9 parts of herbs of tropic ageratum, 3-9 parts of Chinese yams, 6-12 parts of apples, 4-10 parts of unibract fritillary bulb, 3-6 parts of moutan bark and 12-17 parts of cassia bark. The composition completely accords with traditional Chinese medicine principles and physical and psychological characteristics of patients suffering from presbycusis, tinnitus and palpitation, different kinds of composition with different functions can be prepared according to different people on the premise that the composition abides by the general principle, and the composition mainly has the efficacy of clearing heat, facilitating sleeping and soothing nerves.
Owner:马天宝
Compositions and methods for preventing and treating presbycusis
Owner:MARINE BIO
Features
- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
Why Patsnap Eureka
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com